Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Hyperplasia × alovudine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymus Neoplasms 1 Thymoma 1 Sarcoma 1 Hyperplasia 1 Histologically-confirmed Malignancies 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment) 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01610544 2018-07-05

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Hyperplasia, Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡